4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-21-009888
Chief Medical Officer sold 1,470 shares at an average $74.68 ($109,785)
- Chief Medical Officer acquired 4,250 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ho Carole Chief Medical Officer | 2021-02-07 | Option exercise | +4,250 | 169,391 | I | ||
| Ho Carole Chief Medical Officer | 2021-02-09 | Sale | −1,006 | $74.40 | $74,847 | 168,385 | I |
| Ho Carole Chief Medical Officer | 2021-02-09 | Sale | −364 | $75.10 | $27,337 | 168,021 | I |
| Ho Carole Chief Medical Officer | 2021-02-09 | Sale | −100 | $76.00 | $7,600 | 167,921 | I |
| Derivatives | |||||||
| Ho Carole Chief Medical Officer | 2021-02-07 | Option exercise · Restricted Stock Units | −4,250 | 8,500 | D | ||
| Open-market sales · 1,470 sh · avg $74.68 · $109,785 | |||||||
Loading xslF345X03/doc4.xml…